244 related articles for article (PubMed ID: 31290370)
1. Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model.
Depoortère R; Papp M; Gruca P; Lason-Tyburkiewicz M; Niemczyk M; Varney MA; Newman-Tancredi A
J Psychopharmacol; 2019 Nov; 33(11):1456-1466. PubMed ID: 31290370
[TBL] [Abstract][Full Text] [Related]
2. The 5-HT
Papp M; Gruca P; Lason M; Litwa E; Newman-Tancredi A; Depoortère R
Psychopharmacology (Berl); 2023 Nov; 240(11):2419-2433. PubMed ID: 37310446
[TBL] [Abstract][Full Text] [Related]
3. NLX-101, a highly selective 5-HT
Depoortère R; Auclair AL; Newman-Tancredi A
Behav Brain Res; 2021 Mar; 401():113082. PubMed ID: 33358917
[TBL] [Abstract][Full Text] [Related]
4. The selective 5-HT
Głuch-Lutwin M; Sałaciak K; Gawalska A; Jamrozik M; Sniecikowska J; Newman-Tancredi A; Kołaczkowski M; Pytka K
Psychopharmacology (Berl); 2021 Aug; 238(8):2249-2260. PubMed ID: 33973045
[TBL] [Abstract][Full Text] [Related]
5. Activity of Serotonin 5-HT
Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A
ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914
[TBL] [Abstract][Full Text] [Related]
6. The 5-HT
Głuch-Lutwin M; Sałaciak K; Pytka K; Gawalska A; Jamrozik M; Śniecikowska J; Kołaczkowski M; Depoortère RY; Newman-Tancredi A
Behav Brain Res; 2023 Feb; 438():114207. PubMed ID: 36368443
[TBL] [Abstract][Full Text] [Related]
7. NLX-112, a highly selective 5-HT
Newman-Tancredi A; Bardin L; Auclair A; Colpaert F; Depoortère R; Varney MA
Brain Res; 2018 Jun; 1688():1-7. PubMed ID: 29555239
[TBL] [Abstract][Full Text] [Related]
8. The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms.
Papp M; Gruca P; Litwa E; Lason M; Newman-Tancredi A; Depoortère R
J Psychopharmacol; 2024 Jun; ():2698811241254832. PubMed ID: 38825869
[TBL] [Abstract][Full Text] [Related]
9. The selective 5-HT
Powell WH; Annett LE; Depoortere R; Newman-Tancredi A; Iravani MM
Naunyn Schmiedebergs Arch Pharmacol; 2022 Feb; 395(2):149-157. PubMed ID: 34821958
[TBL] [Abstract][Full Text] [Related]
10. The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat.
Jastrzębska-Więsek M; Wesołowska A; Kołaczkowski M; Varney MA; Newman-Tancredi A; Depoortere R
Behav Pharmacol; 2022 Aug; 33(5):333-341. PubMed ID: 35695543
[TBL] [Abstract][Full Text] [Related]
11. Activation of 5-HT
Aguiar RP; Soares LM; Meyer E; da Silveira FC; Milani H; Newman-Tancredi A; Varney M; Prickaerts J; Oliveira RMW
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109832. PubMed ID: 31809832
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline.
Broadbear JH; Depoortere RY; Vacy K; Ralph D; Tunstall BJ; Newman-Tancredi A
Behav Pharmacol; 2021 Dec; 32(8):652-659. PubMed ID: 34751175
[TBL] [Abstract][Full Text] [Related]
13. F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.
Assié MB; Bardin L; Auclair AL; Carilla-Durand E; Depoortère R; Koek W; Kleven MS; Colpaert F; Vacher B; Newman-Tancredi A
Int J Neuropsychopharmacol; 2010 Nov; 13(10):1285-98. PubMed ID: 20059805
[TBL] [Abstract][Full Text] [Related]
14. NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
Iderberg H; McCreary AC; Varney MA; Kleven MS; Koek W; Bardin L; Depoortère R; Cenci MA; Newman-Tancredi A
Exp Neurol; 2015 Sep; 271():335-50. PubMed ID: 26037043
[TBL] [Abstract][Full Text] [Related]
15. Marble Burying in NMRI Male Mice Is Preferentially Sensitive to Pre- Versus Postsynaptic 5-HT1A Receptor Biased Agonists.
Depoortere R; Bardin L; Auclair AL; Bruins Slot LA; Newman-Tancredi A
Pharmacology; 2021; 106(1-2):114-118. PubMed ID: 32950991
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression.
Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
Behav Pharmacol; 2017 Feb; 28(1):1-8. PubMed ID: 27759570
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior.
Murata Y; Yanagihara Y; Mori M; Mine K; Enjoji M
J Affect Disord; 2015 Jul; 180():1-9. PubMed ID: 25879718
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-HT
Depoortère R; Bardin L; Varney MA; Newman-Tancredi A
ACS Chem Neurosci; 2019 Jul; 10(7):3101-3107. PubMed ID: 30929419
[TBL] [Abstract][Full Text] [Related]
19. Piromelatine ameliorates memory deficits associated with chronic mild stress-induced anhedonia in rats.
Fu W; Xie H; Laudon M; Zhou S; Tian S; You Y
Psychopharmacology (Berl); 2016 Jun; 233(12):2229-39. PubMed ID: 27007604
[TBL] [Abstract][Full Text] [Related]
20. Serotonin 5-HT
Levigoureux E; Vidal B; Fieux S; Bouillot C; Emery S; Newman-Tancredi A; Zimmer L
ACS Chem Neurosci; 2019 Jul; 10(7):3108-3119. PubMed ID: 30576601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]